Department of Clinical Pharmacy, Deventer Teaching Hospital, Deventer, The Netherlands.
Unit of PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands.
Pharmacol Res Perspect. 2021 Aug;9(4):e00834. doi: 10.1002/prp2.834.
This study explored the binding of 28 drugs, which were selected based on frequency of concomitant use and chemical properties, to sevelamer and polystyrene sulfonate in vitro. The relative binding was determined by dissolving the investigated drugs alone (=control), together with 800 mg of sevelamer and 15 g of polystyrene sulfonate at different pH levels (1.5, 5.5, and 7.4), respectively. After incubation at 37℃ and shaking for 60 min, the solutions were diluted and centrifuged, and the drug concentrations were quantified with validated analytical assays. The binding assays were performed in threefold. The mean relative binding (MRB) at each pH level was calculated, with a MRB >20% for at least one pH level to be considered as relevant binding. Fourteen and 23 potentially new binding interactions were identified with sevelamer and polystyrene sulfonate, respectively. These potentially new binding interactions have to be studied in vivo to assess their clinical relevance.
本研究探讨了根据同时使用频率和化学性质选择的 28 种药物与司维拉姆和聚苯乙烯磺酸钠在体外的结合情况。通过分别将研究药物溶解(=对照),与 800mg 司维拉姆和 15g 聚苯乙烯磺酸钠在不同 pH 值(1.5、5.5 和 7.4)下孵育 60 分钟,在 37℃下摇动,然后稀释并离心,用经过验证的分析方法定量药物浓度。结合试验进行了三倍。在每个 pH 值水平下计算平均相对结合(MRB),至少有一个 pH 值的 MRB>20%被认为是相关结合。分别用司维拉姆和聚苯乙烯磺酸钠鉴定出 14 种和 23 种潜在的新结合相互作用。这些潜在的新结合相互作用需要在体内进行研究,以评估其临床相关性。